Price $3.85 |
Market Cap
29.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
3.65
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-1.4K
|
FCF
-
|
|
Op. Margin
-67.30%
|
Net Margin
-80.00%
|
ROE
318.90%
|
ROI
-150.10%
|
|
ROA
-90.40%
|
EPS Growth
-0.60%
|
Current Ratio
0.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| LifeVantage Corp (LFVN) | $6.31 | - | 3.20% | 55.7M | Strong Buy |
| ProQR Therapeutics NV (PRQR) | $1.54 | - | - | 131.1M | Strong Buy |
| Psychemedics Corp. (PMD) | $3.78 | - | 6.10% | 26.1M | Strong Buy |
| Collegium Pharmaceutical Inc (COLL) | $22.55 | - | - | 743.4M | Strong Buy |
| Chromadex Corp (CDXC) | $1.42 | - | - | 117.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
